Wave Life Sciences (WVE) Free Cash Flow Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.16% |
| Dec 31, 2025 | -1.10% |
| Sep 30, 2025 | -17.29% |
| Jun 30, 2025 | -3.89% |
| Mar 31, 2025 | -18.69% |
| Dec 31, 2024 | 6.92% |
| Sep 30, 2024 | -1.20% |
| Jun 30, 2024 | 4.44% |
| Mar 31, 2024 | 7.83% |
| Dec 31, 2023 | 1.53% |
| Sep 30, 2023 | -1.36% |
| Jun 30, 2023 | -20.47% |
| Mar 31, 2023 | 35.28% |
| Dec 31, 2022 | 3.51% |
| Sep 30, 2022 | -10.80% |
| Jun 30, 2022 | -2.18% |
| Mar 31, 2022 | -14.47% |
| Dec 31, 2021 | 16.46% |
| Sep 30, 2021 | -18.98% |
| Jun 30, 2021 | -58.04% |
| Mar 31, 2021 | -43.46% |
| Dec 31, 2020 | -33.16% |
| Sep 30, 2020 | -43.23% |
| Jun 30, 2020 | -85.29% |
| Mar 31, 2020 | -74.97% |
| Dec 31, 2019 | -147.57% |